APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Natural APIs (Active Pharmaceutical Ingredients)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Natural APIs (Active Pharmaceutical Ingredients) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174015960328 December 2025197 pages

Choose your research edition.

Industry ResearchNatural APIs (Active Pharmaceutical Ingredients) Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Natural APIs (Active Pharmaceutical Ingredients) Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Natural APIs (Active Pharmaceutical Ingredients) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Natural APIs (Active Pharmaceutical Ingredients) Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Natural APIs (Active Pharmaceutical Ingredients) Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Natural APIs (Active Pharmaceutical Ingredients) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Natural APIs (Active Pharmaceutical Ingredients) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Natural APIs (Active Pharmaceutical Ingredients) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Natural APIs (Active Pharmaceutical Ingredients) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Natural APIs (Active Pharmaceutical Ingredients) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Natural APIs (Active Pharmaceutical Ingredients) include Sanofi SA, Novartis AG, Roquette Freres SA, Kothari Phytochemicals, GSK plc, Evonik Industries AG, Centroflora Group, Cargill and BASF SE, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Natural APIs (Active Pharmaceutical Ingredients) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Natural APIs (Active Pharmaceutical Ingredients) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Natural APIs (Active Pharmaceutical Ingredients) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Natural APIs (Active Pharmaceutical Ingredients) market size, projected growth trends, production technologies, key applications, and end-use industries.

Natural APIs (Active Pharmaceutical Ingredients) Segment by Company

Sanofi SA

Novartis AG

Roquette Freres SA

Kothari Phytochemicals

GSK plc

Evonik Industries AG

Centroflora Group

Cargill

BASF SE

Arboris

Natural APIs (Active Pharmaceutical Ingredients) Segment by Type

Terpenoids

Alkaloids

Lignin

Flavonoids

Anthocyanin

Phenolic Acids

Others

Natural APIs (Active Pharmaceutical Ingredients) Segment by Application

Health Products

Biology

Pharmaceuticals

Others

Natural APIs (Active Pharmaceutical Ingredients) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Natural APIs (Active Pharmaceutical Ingredients) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Natural APIs (Active Pharmaceutical Ingredients) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Natural APIs (Active Pharmaceutical Ingredients).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Natural APIs (Active Pharmaceutical Ingredients) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Natural APIs (Active Pharmaceutical Ingredients) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Natural APIs (Active Pharmaceutical Ingredients) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Natural APIs (Active Pharmaceutical Ingredients) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Natural APIs (Active Pharmaceutical Ingredients) Industry Trends Table 2. Natural APIs (Active Pharmaceutical Ingredients) Industry Drivers Table 3. Natural APIs (Active Pharmaceutical Ingredients) Industry Opportunities and Challenges Table 4. Natural APIs (Active Pharmaceutical Ingredients) Industry Restraints Table 5. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Manufacturers (Tons) & (2021-2026) Table 8. Global Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Manufacturers Table 9. Global Natural APIs (Active Pharmaceutical Ingredients) Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Natural APIs (Active Pharmaceutical Ingredients) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Natural APIs (Active Pharmaceutical Ingredients) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Natural APIs (Active Pharmaceutical Ingredients) Manufacturers, Product Type & Application Table 13. Global Natural APIs (Active Pharmaceutical Ingredients) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Natural APIs (Active Pharmaceutical Ingredients) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Terpenoids Table 17. Major Manufacturers of Alkaloids Table 18. Major Manufacturers of Lignin Table 19. Major Manufacturers of Flavonoids Table 20. Major Manufacturers of Anthocyanin Table 21. Major Manufacturers of Phenolic Acids Table 22. Major Manufacturers of Others Table 23. Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 24. Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Type (2021-2026) & (Tons) Table 25. Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Type (2027-2032) & (Tons) Table 26. Global Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Type (2021-2026) Table 27. Global Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Type (2027-2032) Table 28. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Type 2021 VS 2025 VS 2032 (Tons) Table 29. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Type (2021-2026) & (Tons) Table 30. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Type (2027-2032) & (Tons) Table 31. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Type (2021-2026) Table 32. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Type (2027-2032) Table 33. Major Manufacturers of Health Products Table 34. Major Manufacturers of Biology Table 35. Major Manufacturers of Pharmaceuticals Table 36. Major Manufacturers of Others Table 37. Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 38. Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Application (2021-2026) & (Tons) Table 39. Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Application (2027-2032) & (Tons) Table 40. Global Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Application (2021-2026) Table 41. Global Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Application (2027-2032) Table 42. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Application 2021 VS 2025 VS 2032 (Tons) Table 43. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Application (2021-2026) & (Tons) Table 44. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Application (2027-2032) & (Tons) Table 45. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Application (2021-2026) Table 46. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Application (2027-2032) Table 47. Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 48. Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Region (2021-2026) & (Tons) Table 49. Global Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Region (2021-2026) Table 50. Global Natural APIs (Active Pharmaceutical Ingredients) Sales Forecasted by Region (2027-2032) & (Tons) Table 51. Global Natural APIs (Active Pharmaceutical Ingredients) Sales Forecasted Market Share by Region (2027-2032) Table 52. North America Natural APIs (Active Pharmaceutical Ingredients) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 53. North America Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2021-2026) & (Tons) Table 54. North America Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2027-2032) & (Tons) Table 55. Europe Natural APIs (Active Pharmaceutical Ingredients) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 56. Europe Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2021-2026) & (Tons) Table 57. Europe Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2027-2032) & (Tons) Table 58. Asia Pacific Natural APIs (Active Pharmaceutical Ingredients) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 59. Asia Pacific Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2021-2026) & (Tons) Table 60. Asia Pacific Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2027-2032) & (Tons) Table 61. South America, Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 62. South America, Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2021-2026) & (Tons) Table 63. South America, Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2027-2032) & (Tons) Table 64. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Region (2021-2026) & (US$ Million) Table 66. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Region (2027-2032) & (US$ Million) Table 67. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Region (2021-2026) Table 68. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Region (2027-2032) Table 69. Sanofi SA Company Information Table 70. Sanofi SA Business Overview Table 71. Sanofi SA Natural APIs (Active Pharmaceutical Ingredients) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Sanofi SA Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio Table 73. Sanofi SA Recent Development Table 74. Novartis AG Company Information Table 75. Novartis AG Business Overview Table 76. Novartis AG Natural APIs (Active Pharmaceutical Ingredients) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Novartis AG Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio Table 78. Novartis AG Recent Development Table 79. Roquette Freres SA Company Information Table 80. Roquette Freres SA Business Overview Table 81. Roquette Freres SA Natural APIs (Active Pharmaceutical Ingredients) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Roquette Freres SA Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio Table 83. Roquette Freres SA Recent Development Table 84. Kothari Phytochemicals Company Information Table 85. Kothari Phytochemicals Business Overview Table 86. Kothari Phytochemicals Natural APIs (Active Pharmaceutical Ingredients) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Kothari Phytochemicals Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio Table 88. Kothari Phytochemicals Recent Development Table 89. GSK plc Company Information Table 90. GSK plc Business Overview Table 91. GSK plc Natural APIs (Active Pharmaceutical Ingredients) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. GSK plc Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio Table 93. GSK plc Recent Development Table 94. Evonik Industries AG Company Information Table 95. Evonik Industries AG Business Overview Table 96. Evonik Industries AG Natural APIs (Active Pharmaceutical Ingredients) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Evonik Industries AG Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio Table 98. Evonik Industries AG Recent Development Table 99. Centroflora Group Company Information Table 100. Centroflora Group Business Overview Table 101. Centroflora Group Natural APIs (Active Pharmaceutical Ingredients) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Centroflora Group Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio Table 103. Centroflora Group Recent Development Table 104. Cargill Company Information Table 105. Cargill Business Overview Table 106. Cargill Natural APIs (Active Pharmaceutical Ingredients) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Cargill Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio Table 108. Cargill Recent Development Table 109. BASF SE Company Information Table 110. BASF SE Business Overview Table 111. BASF SE Natural APIs (Active Pharmaceutical Ingredients) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. BASF SE Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio Table 113. BASF SE Recent Development Table 114. Arboris Company Information Table 115. Arboris Business Overview Table 116. Arboris Natural APIs (Active Pharmaceutical Ingredients) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Arboris Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio Table 118. Arboris Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Natural APIs (Active Pharmaceutical Ingredients) Distributors List Table 122. Natural APIs (Active Pharmaceutical Ingredients) Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Natural APIs (Active Pharmaceutical Ingredients) Product Image Figure 2. Global Natural APIs (Active Pharmaceutical Ingredients) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Natural APIs (Active Pharmaceutical Ingredients) Market Size (2021-2032) & (US$ Million) Figure 4. Global Natural APIs (Active Pharmaceutical Ingredients) Sales (2021-2032) & (Tons) Figure 5. Global Natural APIs (Active Pharmaceutical Ingredients) Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Natural APIs (Active Pharmaceutical Ingredients) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Terpenoids Image Figure 9. Alkaloids Image Figure 10. Lignin Image Figure 11. Flavonoids Image Figure 12. Anthocyanin Image Figure 13. Phenolic Acids Image Figure 14. Others Image Figure 15. Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 16. Global Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share 2021 VS 2025 VS 2032 Figure 17. Global Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Type (2021-2032) Figure 18. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Type (2021 VS 2025 VS 2032) & (Tons) Figure 19. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Type (2021-2032) Figure 21. Health Products Image Figure 22. Biology Image Figure 23. Pharmaceuticals Image Figure 24. Others Image Figure 25. Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 26. Global Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Application (2021-2032) Figure 28. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Application (2021 VS 2025 VS 2032) & (Tons) Figure 29. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Application (2021-2032) Figure 31. North America Natural APIs (Active Pharmaceutical Ingredients) Sales and Growth Rate (2021-2032) & (Tons) Figure 32. North America Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Country (2021-2032) Figure 33. U.S. Natural APIs (Active Pharmaceutical Ingredients) Sales and Growth Rate (2021-2032) & (Tons) Figure 34. Canada Natural APIs (Active Pharmaceutical Ingredients) Sales and Growth Rate (2021-2032) & (Tons) Figure 35. Mexico Natural APIs (Active Pharmaceutical Ingredients) Sales and Growth Rate (2021-2032) & (Tons) Figure 36. Europe Natural APIs (Active Pharmaceutical Ingredients) Sales and Growth Rate (2021-2032) & (Tons) Figure 37. Europe Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Country (2021-2032) Figure 38. Germany Natural APIs (Active Pharmaceutical Ingredients) Sales and Growth Rate (2021-2032) & (Tons) Figure 39. France Natural APIs (Active Pharmaceutical Ingredients) Sales and Growth Rate (2021-2032) & (Tons) Figure 40. U.K. Natural APIs (Active Pharmaceutical Ingredients) Sales and Growth Rate (2021-2032) & (Tons) Figure 41. Italy Natural APIs (Active Pharmaceutical Ingredients) Sales and Growth Rate (2021-2032) & (Tons) Figure 42. Netherlands Natural APIs (Active Pharmaceutical Ingredients) Sales and Growth Rate (2021-2032) & (Tons) Figure 43. Asia Pacific Natural APIs (Active Pharmaceutical Ingredients) Sales and Growth Rate (2021-2032) & (Tons) Figure 44. Asia Pacific Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Country (2021-2032) Figure 45. China Natural APIs (Active Pharmaceutical Ingredients) Sales and Growth Rate (2021-2032) & (Tons) Figure 46. Japan Natural APIs (Active Pharmaceutical Ingredients) Sales and Growth Rate (2021-2032) & (Tons) Figure 47. South Korea Natural APIs (Active Pharmaceutical Ingredients) Sales and Growth Rate (2021-2032) & (Tons) Figure 48. Southeast Asia Natural APIs (Active Pharmaceutical Ingredients) Sales and Growth Rate (2021-2032) & (Tons) Figure 49. India Natural APIs (Active Pharmaceutical Ingredients) Sales and Growth Rate (2021-2032) & (Tons) Figure 50. Australia Natural APIs (Active Pharmaceutical Ingredients) Sales and Growth Rate (2021-2032) & (Tons) Figure 51. South America, Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Sales and Growth Rate (2021-2032) & (Tons) Figure 52. South America, Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Country (2021-2032) Figure 53. Brazil Natural APIs (Active Pharmaceutical Ingredients) Sales and Growth Rate (2021-2032) & (Tons) Figure 54. South Africa Natural APIs (Active Pharmaceutical Ingredients) Sales and Growth Rate (2021-2032) & (Tons) Figure 55. Saudi Arabia Natural APIs (Active Pharmaceutical Ingredients) Sales and Growth Rate (2021-2032) & (Tons) Figure 56. Turkey Natural APIs (Active Pharmaceutical Ingredients) Sales and Growth Rate (2021-2032) & (Tons) Figure 57. Argentina Natural APIs (Active Pharmaceutical Ingredients) Sales and Growth Rate (2021-2032) & (Tons) Figure 58. UAE Natural APIs (Active Pharmaceutical Ingredients) Sales and Growth Rate (2021-2032) & (Tons) Figure 59. Egypt Natural APIs (Active Pharmaceutical Ingredients) Sales and Growth Rate (2021-2032) & (Tons) Figure 60. Chile Natural APIs (Active Pharmaceutical Ingredients) Sales and Growth Rate (2021-2032) & (Tons) Figure 61. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America Natural APIs (Active Pharmaceutical Ingredients) Revenue (2021-2032) & (US$ Million) Figure 64. North America Natural APIs (Active Pharmaceutical Ingredients) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Natural APIs (Active Pharmaceutical Ingredients) Revenue (2021-2032) & (US$ Million) Figure 66. Europe Natural APIs (Active Pharmaceutical Ingredients) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Natural APIs (Active Pharmaceutical Ingredients) Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific Natural APIs (Active Pharmaceutical Ingredients) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. Natural APIs (Active Pharmaceutical Ingredients) Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Natural APIs (Active Pharmaceutical Ingredients) Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Terpenoids
  • Alkaloids
  • Lignin
  • Flavonoids
  • Anthocyanin
  • Phenolic Acids
  • Others
Applications
  • Health Products
  • Biology
  • Pharmaceuticals
  • Others
Companies covered
  • Sanofi SA
  • Novartis AG
  • Roquette Freres SA
  • Kothari Phytochemicals
  • GSK plc
  • Evonik Industries AG
  • Centroflora Group
  • Cargill
  • BASF SE
  • Arboris

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Natural APIs (Active Pharmaceutical Ingredients) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Natural APIs (Active Pharmaceutical Ingredients) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Natural APIs (Active Pharmaceutical Ingredients) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Natural APIs (Active Pharmaceutical Ingredients) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Natural APIs (Active Pharmaceutical Ingredients) Market Dynamics
  1. 2.1 Natural APIs (Active Pharmaceutical Ingredients) Industry Trends
  2. 2.2 Natural APIs (Active Pharmaceutical Ingredients) Industry Drivers
  3. 2.3 Natural APIs (Active Pharmaceutical Ingredients) Industry Opportunities and Challenges
  4. 2.4 Natural APIs (Active Pharmaceutical Ingredients) Industry Restraints
3 Natural APIs (Active Pharmaceutical Ingredients) Market by Manufacturers
  1. 3.1 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Natural APIs (Active Pharmaceutical Ingredients) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Natural APIs (Active Pharmaceutical Ingredients) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Natural APIs (Active Pharmaceutical Ingredients) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Natural APIs (Active Pharmaceutical Ingredients) Manufacturers, Product Type & Application
  7. 3.7 Global Natural APIs (Active Pharmaceutical Ingredients) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Natural APIs (Active Pharmaceutical Ingredients) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Natural APIs (Active Pharmaceutical Ingredients) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Natural APIs (Active Pharmaceutical Ingredients) Tier 1, Tier 2, and Tier 3
4 Natural APIs (Active Pharmaceutical Ingredients) Market by Type
  1. 4.1 Natural APIs (Active Pharmaceutical Ingredients) Type Introduction
  2. 4.1.1 Terpenoids
  3. 4.1.2 Alkaloids
  4. 4.1.3 Lignin
  5. 4.1.4 Flavonoids
  6. 4.1.5 Anthocyanin
  7. 4.1.6 Phenolic Acids
  8. 4.1.7 Others
  9. 4.2 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Type
  10. 4.2.1 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Type (2021-2032)
  12. 4.2.3 Global Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Type (2021-2032)
  13. 4.3 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Type
  14. 4.3.1 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Type (2021-2032)
  16. 4.3.3 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Type (2021-2032)
5 Natural APIs (Active Pharmaceutical Ingredients) Market by Application
  1. 5.1 Natural APIs (Active Pharmaceutical Ingredients) Application Introduction
  2. 5.1.1 Health Products
  3. 5.1.2 Biology
  4. 5.1.3 Pharmaceuticals
  5. 5.1.4 Others
  6. 5.2 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Application
  7. 5.2.1 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Application (2021-2032)
  9. 5.2.3 Global Natural APIs (Active Pharmaceutical Ingredients) Sales Market Share by Application (2021-2032)
  10. 5.3 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Application
  11. 5.3.1 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Application (2021-2032)
  13. 5.3.3 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Application (2021-2032)
6 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Region
  1. 6.1 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Region (2021-2032)
  3. 6.2.1 Global Natural APIs (Active Pharmaceutical Ingredients) Sales by Region (2021-2026)
  4. 6.2.2 Global Natural APIs (Active Pharmaceutical Ingredients) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Natural APIs (Active Pharmaceutical Ingredients) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Natural APIs (Active Pharmaceutical Ingredients) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Natural APIs (Active Pharmaceutical Ingredients) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Region
  1. 7.1 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Region
  2. 7.1.1 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Region (2021-2026)
  4. 7.1.3 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue by Region (2027-2032)
  5. 7.1.4 Global Natural APIs (Active Pharmaceutical Ingredients) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Natural APIs (Active Pharmaceutical Ingredients) Revenue (2021-2032)
  8. 7.2.2 North America Natural APIs (Active Pharmaceutical Ingredients) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Natural APIs (Active Pharmaceutical Ingredients) Revenue (2021-2032)
  11. 7.3.2 Europe Natural APIs (Active Pharmaceutical Ingredients) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Natural APIs (Active Pharmaceutical Ingredients) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Natural APIs (Active Pharmaceutical Ingredients) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Natural APIs (Active Pharmaceutical Ingredients) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi SA
  2. 8.1.1 Sanofi SA Company Information
  3. 8.1.2 Sanofi SA Business Overview
  4. 8.1.3 Sanofi SA Natural APIs (Active Pharmaceutical Ingredients) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi SA Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
  6. 8.1.5 Sanofi SA Recent Developments
  7. 8.2 Novartis AG
  8. 8.2.1 Novartis AG Company Information
  9. 8.2.2 Novartis AG Business Overview
  10. 8.2.3 Novartis AG Natural APIs (Active Pharmaceutical Ingredients) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis AG Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
  12. 8.2.5 Novartis AG Recent Developments
  13. 8.3 Roquette Freres SA
  14. 8.3.1 Roquette Freres SA Company Information
  15. 8.3.2 Roquette Freres SA Business Overview
  16. 8.3.3 Roquette Freres SA Natural APIs (Active Pharmaceutical Ingredients) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Roquette Freres SA Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
  18. 8.3.5 Roquette Freres SA Recent Developments
  19. 8.4 Kothari Phytochemicals
  20. 8.4.1 Kothari Phytochemicals Company Information
  21. 8.4.2 Kothari Phytochemicals Business Overview
  22. 8.4.3 Kothari Phytochemicals Natural APIs (Active Pharmaceutical Ingredients) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Kothari Phytochemicals Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
  24. 8.4.5 Kothari Phytochemicals Recent Developments
  25. 8.5 GSK plc
  26. 8.5.1 GSK plc Company Information
  27. 8.5.2 GSK plc Business Overview
  28. 8.5.3 GSK plc Natural APIs (Active Pharmaceutical Ingredients) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GSK plc Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
  30. 8.5.5 GSK plc Recent Developments
  31. 8.6 Evonik Industries AG
  32. 8.6.1 Evonik Industries AG Company Information
  33. 8.6.2 Evonik Industries AG Business Overview
  34. 8.6.3 Evonik Industries AG Natural APIs (Active Pharmaceutical Ingredients) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Evonik Industries AG Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
  36. 8.6.5 Evonik Industries AG Recent Developments
  37. 8.7 Centroflora Group
  38. 8.7.1 Centroflora Group Company Information
  39. 8.7.2 Centroflora Group Business Overview
  40. 8.7.3 Centroflora Group Natural APIs (Active Pharmaceutical Ingredients) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Centroflora Group Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
  42. 8.7.5 Centroflora Group Recent Developments
  43. 8.8 Cargill
  44. 8.8.1 Cargill Company Information
  45. 8.8.2 Cargill Business Overview
  46. 8.8.3 Cargill Natural APIs (Active Pharmaceutical Ingredients) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Cargill Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
  48. 8.8.5 Cargill Recent Developments
  49. 8.9 BASF SE
  50. 8.9.1 BASF SE Company Information
  51. 8.9.2 BASF SE Business Overview
  52. 8.9.3 BASF SE Natural APIs (Active Pharmaceutical Ingredients) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 BASF SE Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
  54. 8.9.5 BASF SE Recent Developments
  55. 8.10 Arboris
  56. 8.10.1 Arboris Company Information
  57. 8.10.2 Arboris Business Overview
  58. 8.10.3 Arboris Natural APIs (Active Pharmaceutical Ingredients) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Arboris Natural APIs (Active Pharmaceutical Ingredients) Product Portfolio
  60. 8.10.5 Arboris Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Natural APIs (Active Pharmaceutical Ingredients) Value Chain Analysis
  2. 9.1.1 Natural APIs (Active Pharmaceutical Ingredients) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Natural APIs (Active Pharmaceutical Ingredients) Production Mode & Process
  6. 9.2 Natural APIs (Active Pharmaceutical Ingredients) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Natural APIs (Active Pharmaceutical Ingredients) Distributors
  9. 9.2.3 Natural APIs (Active Pharmaceutical Ingredients) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst